| P50 | author | Arik J Hone | Q88416433 |
| P2093 | author name string | J Michael McIntosh | |
| P2860 | cites work | Nicotine receptor partial agonists for smoking cessation | Q24185773 |
| | Molecular cloning and mapping of the human nicotinic acetylcholine receptor alpha10 (CHRNA10) | Q24291220 |
| | Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation | Q24338135 |
| | alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells | Q24629329 |
| | Mammalian nicotinic acetylcholine receptors: from structure to function | Q24647069 |
| | Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity | Q24669539 |
| | Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors | Q24673308 |
| | Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures | Q24803737 |
| | Neuronal Nicotinic Acetylcholine Receptor Structure and Function and Response to Nicotine | Q26782610 |
| | Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors | Q28245329 |
| | Potentiation of human alpha4beta2 neuronal nicotinic receptors by a Flustra foliacea metabolite | Q28295441 |
| | Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom | Q28338203 |
| | Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats | Q28377667 |
| | α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties | Q28548435 |
| | The cholinergic anti-inflammatory pathway: a critical review | Q38177419 |
| | Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation | Q38204497 |
| | Additional acetylcholine (ACh) binding site at alpha4/alpha4 interface of (alpha4beta2)2alpha4 nicotinic receptor influences agonist sensitivity | Q38264151 |
| | Diversity of native nicotinic receptor subtypes in mammalian brain | Q38280489 |
| | Unorthodox Acetylcholine Binding Sites Formed by α5 and β3 Accessory Subunits in α4β2* Nicotinic Acetylcholine Receptors | Q38435927 |
| | Acetylcholine nicotinic receptor subtypes in chromaffin cells. | Q38632845 |
| | α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line | Q38696785 |
| | Exploring the positive allosteric modulation of human α7 nicotinic receptors from a single-channel perspective | Q38790173 |
| | Usefulness of α7 nicotinic receptor messenger RNA levels in peripheral blood mononuclear cells as a marker for cholinergic antiinflammatory pathway activity in septic patients: results of a pilot study | Q38968670 |
| | Acute activation, desensitization and smoldering activation of human acetylcholine receptors | Q39061997 |
| | Anti-hypersensitive effect of intramuscular administration of αO-conotoxin GeXIVA[1,2] and GeXIVA[1,4] in rats of neuropathic pain | Q39177181 |
| | Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neurons | Q39323336 |
| | Physiological functions of the cholinergic system in immune cells. | Q39335204 |
| | α9-containing nicotinic acetylcholine receptors and the modulation of pain. | Q39405111 |
| | αO-Conotoxin GeXIVA disulfide bond isomers exhibit differential sensitivity for various nicotinic acetylcholine receptors but retain potency and selectivity for the human α9α10 subtype. | Q39628410 |
| | Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors | Q39785082 |
| | The antinociceptive response to nicotinic agonists in a mouse model of postoperative pain | Q40057468 |
| | Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1β Release. | Q40705339 |
| | Chemokines (CCL3, CCL4, and CCL5) Inhibit ATP-Induced Release of IL-1β by Monocytic Cells | Q41056611 |
| | RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia. | Q41075047 |
| | Nicotine and sympathetic neurotransmission | Q41436466 |
| | Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties | Q41817415 |
| | Expression patterns for nicotinic acetylcholine receptor subunit genes in smoking-related lung cancers. | Q41833549 |
| | Evidence for the tonic inhibition of spinal pain by nicotinic cholinergic transmission through primary afferents | Q41953655 |
| | Two distinct allosteric binding sites at α4β2 nicotinic acetylcholine receptors revealed by NS206 and NS9283 give unique insights to binding activity-associated linkage at Cys-loop receptors. | Q42123087 |
| | Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells | Q28576034 |
| | Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in rat dorsal root ganglion neurons | Q28578187 |
| | Neuronal alpha-bungarotoxin receptors are alpha7 subunit homomers | Q28579166 |
| | Nicotinic acetylcholine receptor subtypes in rat superior cervical ganglion neurons as studied by sequential application of two alpha-subunit-specific antibodies | Q28582542 |
| | Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors | Q28655994 |
| | Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin | Q29615449 |
| | α-conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement | Q30402093 |
| | Nicotinic receptor alpha 7-subunits are coupled to the stimulation of nitric oxide synthase in rat dorsal root ganglion neurons | Q33187998 |
| | A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors | Q33218073 |
| | Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation | Q33486953 |
| | Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats | Q33764231 |
| | A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides | Q33801299 |
| | GTS-21, an α7-nicotinic acetylcholine receptor agonist, modulates Th1 differentiation in CD4(+) T cells from patients with rheumatoid arthritis | Q33837444 |
| | Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10. | Q33871018 |
| | Modulators of nicotinic acetylcholine receptors as analgesics. | Q33976207 |
| | Intrathecal injection of an alpha seven nicotinic acetylcholine receptor agonist attenuates gp120-induced mechanical allodynia and spinal pro-inflammatory cytokine profiles in rats | Q33988241 |
| | Antinociceptive and anti-inflammatory effects of choline in a mouse model of postoperative pain | Q33990803 |
| | Nicotinic receptor Alpha7 expression during mouse adrenal gland development | Q34004724 |
| | A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit | Q34106060 |
| | Subtype-specific mechanisms for functional interaction between α6β4* nicotinic acetylcholine receptors and P2X receptors | Q34125240 |
| | Nicotinic receptors on rat alveolar macrophages dampen ATP-induced increase in cytosolic calcium concentration. | Q34203150 |
| | Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit | Q34216728 |
| | A new IRAK-M-mediated mechanism implicated in the anti-inflammatory effect of nicotine via α7 nicotinic receptors in human macrophages | Q34258676 |
| | α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia | Q34333395 |
| | Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes. | Q34340033 |
| | Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes | Q34365845 |
| | ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model | Q34394729 |
| | Heterogeneity of nicotinic receptor class and subunit mRNA expression among individual parasympathetic neurons from rat intracardiac ganglia. | Q34412766 |
| | A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization. | Q34414363 |
| | Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors | Q34458388 |
| | ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization | Q34467462 |
| | Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor | Q34492038 |
| | The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation | Q34520745 |
| | The activation of nicotinic acetylcholine receptors enhances the inhibitory synaptic transmission in the deep dorsal horn neurons of the adult rat spinal cord | Q42143977 |
| | Discovery of non-peptide, small molecule antagonists of α9α10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain | Q42182053 |
| | Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells | Q42380131 |
| | The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain. | Q42406043 |
| | Co-expression of alpha7 and beta2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons | Q42443864 |
| | α4β2 neuronal nicotinic receptor positive allosteric modulation: an approach for improving the therapeutic index of α4β2 nAChR agonists in pain | Q42730553 |
| | Selective potentiation of gabapentin-mediated antinociception in the rat formalin test by the nicotinic acetylcholine receptor agonist ABT-594. | Q43012483 |
| | Analgesic α-conotoxins Vc1.1 and RgIA inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice | Q43109150 |
| | Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain | Q43157456 |
| | CNSB004 (Leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain | Q43225441 |
| | Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses | Q43257205 |
| | Inhibition of neuronal nitric oxide synthase results in neurodegenerative changes in the axotomised dorsal root ganglion neurons: evidence for a neuroprotective role of nitric oxide in vivo | Q43580921 |
| | A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain | Q43736517 |
| | Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes. | Q43766593 |
| | Pharmacological properties of nicotinic acetylcholine receptors expressed by guinea pig small intestinal myenteric neurons. | Q44106312 |
| | Modulation of inhibitory synaptic activity by a non-alpha4beta2, non-alpha7 subtype of nicotinic receptors in the substantia gelatinosa of adult rat spinal cord | Q44266707 |
| | A novel alpha-conotoxin identified by gene sequencing is active in suppressing the vascular response to selective stimulation of sensory nerves in vivo. | Q44461352 |
| | Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies | Q44524230 |
| | Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. | Q44676738 |
| | Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors | Q44823866 |
| | The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model | Q44877375 |
| | Nicotinic receptor mediated stimulation of NO-generation in neurons of rat thoracic dorsal root ganglia. | Q44890624 |
| | Nicotine differentially activates inhibitory and excitatory neurons in the dorsal spinal cord | Q44906066 |
| | Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat. | Q45008678 |
| | New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs | Q45065606 |
| | Nicotinic AChR in subclassified capsaicin-sensitive and -insensitive nociceptors of the rat DRG. | Q45105885 |
| | Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis | Q45122630 |
| | Nicotinic modulation of GABAergic synaptic transmission in the spinal cord dorsal horn. | Q45223113 |
| | Efficacy and safety of the α4β2 neuronal nicotinic receptor agonist ABT-894 in patients with diabetic peripheral neuropathic pain. | Q46019859 |
| | The effect of peripherally administered CDP-choline in an acute inflammatory pain model: the role of alpha7 nicotinic acetylcholine receptor | Q46048101 |
| | Neuronal acetylcholine receptors with alpha7 subunits are concentrated on somatic spines for synaptic signaling in embryonic chick ciliary ganglia | Q46187986 |
| | Reduced expression of nicotinic alpha subunits 3, 7, 9 and 10 in lesional and nonlesional atopic dermatitis skin but enhanced expression of alpha subunits 3 and 5 in mast cells | Q46451581 |
| | Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway | Q46605002 |
| | Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones | Q46718997 |
| | Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR. | Q46918125 |
| | Surfactant inhibits ATP-induced release of interleukin-1β via nicotinic acetylcholine receptors | Q47917345 |
| | Therapeutic concentrations of varenicline in the presence of nicotine increase action potential firing in human adrenal chromaffin cells | Q48037427 |
| | The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment | Q48056690 |
| | The alpha-bungarotoxin-binding nicotinic acetylcholine receptor from rat brain contains only the alpha7 subunit | Q48628440 |
| | Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonists | Q48665044 |
| | Unraveling the high- and low-sensitivity agonist responses of nicotinic acetylcholine receptors. | Q48667658 |
| | Functional nicotinic acetylcholine receptors that mediate ganglionic transmission in cardiac parasympathetic neurons. | Q48887869 |
| | Cholinergic synaptic inhibition of inner hair cells in the neonatal mammalian cochlea. | Q50495695 |
| | Coexpression and spatial association of nicotinic acetylcholine receptor subunits alpha7 and alpha10 in rat sympathetic neurons. | Q54565240 |
| | Intravenous Injection of Leconotide, an Omega Conotoxin: Synergistic Antihyperalgesic Effects with Morphine in a Rat Model of Bone Cancer Pain | Q60605623 |
| | Conopeptides: From deadly venoms to novel therapeutics | Q73451199 |
| | Differential expression of alpha-bungarotoxin-sensitive neuronal nicotinic receptors in adrenergic chromaffin cells: a role for transcription factor Egr-1 | Q73581851 |
| | Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain | Q73841757 |
| | Identification of nicotinic acetylcholine receptors on lymphocytes in the periphery as well as thymus in mice | Q73985135 |
| | Immunohistochemical detection of nicotinic acetylcholine receptor subunits alpha9 and alpha10 in rat lung isografts and allografts | Q79853956 |
| | Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose Ganglia | Q80044490 |
| | alpha7 Nicotinic acetylcholine receptor stimulation inhibits lipopolysaccharide-induced interleukin-18 and -12 production in monocytes | Q80230278 |
| | Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7 | Q80249771 |
| | Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial | Q82265845 |
| | Modulation of GABAergic synaptic transmission by terminal nicotinic acetylcholine receptors in the central autonomic nucleus of the neonatal rat spinal cord | Q83296558 |
| | Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats | Q84213099 |
| | The antihyperalgesic effect of cytidine-5'-diphosphate-choline in neuropathic and inflammatory pain models | Q84750685 |
| | Activation of α7nAChR by nicotine reduced the Th17 response in CD4(+)T lymphocytes | Q88119963 |
| | Functional α7β2 nicotinic acetylcholine receptors expressed in hippocampal interneurons exhibit high sensitivity to pathological level of amyloid β peptides | Q34526528 |
| | Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice | Q34539248 |
| | Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them | Q34549732 |
| | Distinct profiles of alpha7 nAChR positive allosteric modulation revealed by structurally diverse chemotypes | Q34636910 |
| | An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo | Q34648974 |
| | Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors | Q34764699 |
| | α7-cholinergic receptor mediates vagal induction of splenic norepinephrine | Q34872582 |
| | The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor | Q35034364 |
| | Short- and long-term enhancement of excitatory transmission in the spinal cord dorsal horn by nicotinic acetylcholine receptors. | Q35144346 |
| | The interface between cholinergic pathways and the immune system and its relevance to arthritis | Q35228289 |
| | The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic | Q35547518 |
| | Two novel α7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in mice | Q35548484 |
| | Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states | Q35586093 |
| | An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors | Q35662305 |
| | Nicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4* subtype. | Q35790283 |
| | Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia | Q35837691 |
| | Pharmacological characterization of native α7 nicotinic ACh receptors and their contribution to depolarization-elicited exocytosis in human chromaffin cells. | Q35853230 |
| | Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats | Q35853738 |
| | Population analyses of efficacy and safety of ABT-594 in subjects with diabetic peripheral neuropathic pain | Q35888354 |
| | Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist. | Q35910100 |
| | Nicotinic Acetylcholine Receptors Modulate Bone Marrow-Derived Pro-Inflammatory Monocyte Production and Survival | Q35939425 |
| | Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variant | Q36126982 |
| | α-Conotoxins Identify the α3β4* Subtype as the Predominant Nicotinic Acetylcholine Receptor Expressed in Human Adrenal Chromaffin Cells | Q36186102 |
| | Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA. | Q36208114 |
| | The vagus nerve and the nicotinic anti-inflammatory pathway | Q36214006 |
| | A Novel α2/α4 Subtype-selective Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors Acting from the C-tail of an α Subunit | Q36323450 |
| | Pharmacological stimulation of the cholinergic antiinflammatory pathway | Q36370255 |
| | Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation | Q36403437 |
| | Effects of α7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models | Q36463363 |
| | The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models | Q36497623 |
| | α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief | Q36517174 |
| | Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis | Q36597282 |
| | Differential modulation of EAE by α9*- and β2*-nicotinic acetylcholine receptors | Q36681341 |
| | In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model | Q36929434 |
| | Phosphocholine - an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors | Q37044492 |
| | Pentameric concatenated (alpha4)(2)(beta2)(3) and (alpha4)(3)(beta2)(2) nicotinic acetylcholine receptors: subunit arrangement determines functional expression | Q37230743 |
| | The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors | Q37246699 |
| | The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. | Q37254561 |
| | Oral choline supplementation for postoperative pain | Q37345030 |
| | Novel ω-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration. | Q37369881 |
| | The unique α4+/-α4 agonist binding site in (α4)3(β2)2 subtype nicotinic acetylcholine receptors permits differential agonist desensitization pharmacology versus the (α4)2(β2)3 subtype | Q37405338 |
| | The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface | Q37583624 |
| | Expeditious synthesis, enantiomeric resolution, and enantiomer functional characterization of (4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4BP-TQS): an allosteric agonist-positive allosteric modulator of α7 nicoti | Q37600251 |
| | Attenuation of Collagen-Induced Arthritis in rat by nicotinic alpha7 receptor partial agonist GTS-21. | Q37639837 |
| | The therapeutic promise of positive allosteric modulation of nicotinic receptors | Q37695734 |
| | Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain | Q37695948 |
| | Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases | Q37800819 |
| | Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads | Q37954299 |
| | P2X receptor antagonists for pain management: examination of binding and physicochemical properties | Q37956570 |
| | P2X receptors as drug targets | Q38068620 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuropathic pain | Q2798704 |
| P304 | page(s) | 1045-1062 | |
| P577 | publication date | 2017-10-27 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Nicotinic acetylcholine receptors in neuropathic and inflammatory pain | |
| P478 | volume | 592 | |